Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02748356 · ClinicalTrials.gov registry record · Phase 2
Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB
A Phase 2 study, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT02748356: Completed Phase 2 study, sponsored by Medstar Health Research Institute.
NCT02748356 is a Phase 2 study that has completed, run by Medstar Health Research Institute. The registered enrollment target is 7 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02748356, a Phase 2 study, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
As a collaborative effort between MedStar National Rehabilitation Hospital (NRH), Children's National Medical Center (CNMC) Department of Urology, Children's Research Institute (CRI) Center for Genetic Medicine Research, Georgetown University, and MedStar Georgetown University Hospital, the overall objective of this study is to develop, validate, and assess a patient-initiated, probiotic-based, selfmanagement protocol that is initiated at the time of urinary symptoms. The self-management protocol will allow patients to manage urinary symptoms and avoid potentially unnecessary antibiotic use, and provide a readily-available means of maintaining health, function, and independence throughout the lifespan.
Primary Outcome
Total Adverse Events (AE + Serious AE) per participants
Interventions
- DRUG Lactobacillus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-01 |
| Est. Completion | 2018-12-31 |
| Phase | Phase 2 |
What the finished NCT02748356 record still lists
NCT02748356 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Lactobacillus is the first listed.
NCT02748356 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02748356 about?
NCT02748356 is a clinical study titled "Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB". As a collaborative effort between MedStar National Rehabilitation Hospital (NRH), Children's National Medical Center (CNMC) Department of Urology, Children's Research Institute (CRI) Center for Genetic Medicine Research, Georgetown University, and MedStar Georgetown University Hospital, the overall ...
What is the current status of trial NCT02748356?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2016-01. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT02748356?
The interventions under investigation include: Lactobacillus (DRUG).
Who is sponsoring clinical trial NCT02748356?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02748356's enrollment target sits among peer trials
7 1996th of 2000 higher than 5 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia